Aurobindo Pharma

Aurobindo Pharma Ltd Key Ratios

NSEBSE

₹1,170.9

(0.84%)

Jun 10, 2025|12:00:00 AM

Invest wise with Expert advice

QUICKLINKS FOR Aurobindo Pharma Ltd

ConsolidatedStandalone

GraphTable

Y/e 31 Mar	Mar-2022	Mar-2021	Mar-2020	Mar-2018
Growth matrix (%)
Revenue growth	-5.32	7.25	40.3	10.41
Op profit growth	-17.74	9.64	28.96	9.82
EBIT growth	-23.14	13.92	23.21	6.28
Net profit growth	-50.36	88.44	16.82	5.27
Profitability ratios (%)
OPM	18.7	21.52	21.05	22.91
EBIT margin	15.26	18.8	17.7	20.15
Net profit margin	11.29	21.53	12.25	14.71
RoCE	12.79	18.29	20.44	21.98
RoNW	2.84	6.88	4.96	5.75
RoA	2.36	5.23	3.53	4.01
Per share ratios (₹)
EPS	45.18	91.04	48.54	41.35
Dividend per share	9	4	3	2.5
Cash EPS	25.96	73.03	31.81	31.83
Book value per share	419.42	374.28	287.15	199.35
Valuation ratios
P/E	14.8	9.68	8.5	13.47
P/CEPS	25.75	12.06	12.98	17.5
P/B	1.59	2.35	1.43	2.79
EV/EBIDTA	8.04	9.01	5.37	9.32
Payout (%)
Dividend payout	9.95	0	0	6.04
Tax payout	-20.54	-43.83	-24.13	-25.24
Liquidity ratios
Debtor days	58.47	57.59	58.43	64.8
Inventory days	129.16	123.32	107.12	112.94
Creditor days	-58.64	-55.93	-53.39	-70.89
Leverage ratios
Interest coverage	-73.61	-62.54	-13.4	-42.7
Net debt / equity	-0.05	0	0.17	0.3
Net debt / op. profit	-0.3	-0.02	0.61	0.92
Cost breakup (₹)
Material costs	-43.23	-39.97	-42.14	-41.01
Employee costs	-14.71	-14.26	-13.93	-12.94
Other costs	-23.35	-24.23	-22.85	-23.12